Jeff Goater - May 11, 2021 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role: Director
Signature: /s/ Scott E. Royer, Attorney-in-Fact for Jeff Goater
Stock symbol: VCNX
Transactions as of: May 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/12/2021, 04:27 PM
Next filing: Jun 11, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VCNX	Common Stock						300	May 11, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCNX	Stock Option (Right to Buy)	Award	$0	+28.6K		$0.00	28.6K	May 11, 2021	Common Stock	28.6K	$2.15	Direct	F4
holding	VCNX	Stock Option (Right to Buy)						6K	May 11, 2021	Common Stock	6K	$14.90	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						2.24K	May 11, 2021	Common Stock	2.24K	$13.60	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						7.72K	May 11, 2021	Common Stock	7.72K	$7.78	Direct	F2
holding	VCNX	Stock Option (Right to Buy)						15.7K	May 11, 2021	Common Stock	15.7K	$3.95	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Exercisable in full as of the date of this report.
F2	This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F3	This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F4	This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.